Policy & Advocacy Massachusetts at BIO 2025: Leaning on Strengths to Lead the Future of Life Sciences Jun 26, 2025
Policy & Advocacy MassBio statement opposing ‘Most Favored Nation’ prescription drug pricing policy May 12, 2025
Policy & Advocacy MassBio Statement on President Trump’s executive order on drug pricing Apr 16, 2025
Policy & Advocacy The Commonwealth’s unwavering commitment to science, research, and therapies Apr 07, 2025
Policy & Advocacy MassBio comments on termination of billions of dollars in indirect NIH funding Feb 10, 2025
Policy & Advocacy Statement on CMS listing 15 additional drugs subject to price negotiations Jan 17, 2025
Policy & Advocacy Post-Election Healthcare and Biotech Outlook: Implications for Massachusetts and Beyond Dec 05, 2024
